Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Review Results & Options With A Board-Certified Aspire Physician In-depth consultation Start Your Personalized Treatment Get started this week
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
Almost immediately after injection, the nutrients injected into the body begin working
Dizziness or lightheadedness: Uncommon, usually mild and resolves with adjustment
CMS Extends Medicares Short-Term Bridge Program for GLP-1 Obesity Drug Coverage The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on January 1, 2027
If you experience persistent tiredness, its important to consult with your healthcare provider to adjust your treatment plan
US$ 23.44
US$ 27.83
US$ 29.84
